Facility will be built in two phases, with some additional rezoning in the works
By Corina Vanek | Phoenix Business Journal
Arizona Isotope Science Research Corp. is preparing to begin construction on a facility in Goodyear to manufacture isotopes that will allow medical professionals to clearly see abnormal blood flow in patients with cardiovascular conditions and cancer.
The company got the go-ahead from the city of Goodyear in December to allow hazardous materials, in this case the radioactive chemical element strontium-82 and rubidium-82, to be produced in the facility, to be located near Bullard Avenue and La Estrella. Now, the company is finishing up some other zoning work to remove old regulations from the site before it begins development, facility President and COO Greg Brooksby said.
“So far, we are meeting the timelines the way we want to,” Brooksby said. “We are projecting isotopes will be on the market in the fourth quarter of 2020.”
